Pediatric low-grade gliomas (pLGG) are the most common type of brain tumor in children, with around 1700 cases diagnosed each year. Although these tumors grow and spread more slowly than high-grade tumors, half of the children who undergo surgery will end up relapsing and require additional treatments.
If your child has been diagnosed with pLGG, having a better understanding of this disease can help you make informed decisions about your child’s journey from diagnosis through survivorship. In this on-demand webinar from May 2023 supported by Day One Biopharmaceuticals, Dr. Tab Cooney, the Medical Director of Day One Biopharmaceuticals, and the Pediatric Brain Tumor Foundation came together to educate the community about common types of pLGGs and treatments.
If you have questions, need support, or would like a copy of the presentation slides, please email [email protected].